DrugPatentWatch Database Preview
Drugs in MeSH Category Enzyme Inhibitors
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 071867-001 | Sep 9, 1987 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sandoz Inc | DIGOXIN | digoxin | INJECTABLE;INJECTION | 040481-001 | Aug 21, 2003 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Wyeth Ayerst | WYAMYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062123-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Teva Pharms Usa | VIGABATRIN | vigabatrin | TABLET;ORAL | 209822-001 | Jan 14, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 076243-002 | Feb 24, 2003 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Strides Pharma | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 209421-002 | Jun 8, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Barr | ERYTHROMYCIN ESTOLATE | erythromycin estolate | CAPSULE;ORAL | 062162-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
